| Target Price | $295.80 |
| Price | $281.46 |
| Potential |
5.09%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target CME Group a 2026 .
The average CME Group a target price is $295.80.
This is
5.09%
register free of charge
$329.70
17.14%
register free of charge
$203.01
27.87%
register free of charge
|
|
| A rating was issued by 22 analysts: 12 Analysts recommend CME Group a to buy, 7 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CME Group a stock has an average upside potential 2026 of
5.09%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 10.21 | 6.54 |
| 5.94% | 35.93% | |
| EBITDA Margin | 81.76% | 70.86% |
| 2.08% | 13.34% | |
| Net Margin | 34.10% | 61.84% |
| 16.19% | 81.34% |
19 Analysts have issued a sales forecast CME Group a 2025 . The average CME Group a sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an CME Group a EBITDA forecast 2025. The average CME Group a EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
20 CME Group a Analysts have issued a net profit forecast 2025. The average CME Group a net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 9.67 | 11.22 |
| 9.14% | 16.03% | |
| P/E | 25.08 | |
| EV/Sales | 15.65 |
20 Analysts have issued a CME Group a forecast for earnings per share. The average CME Group a EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler |
Locked
➜
Locked
|
Locked | Nov 13 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Oct 23 2025 |
| Deutsche Bank |
Locked
➜
Locked
|
Locked | Oct 23 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Oct 23 2025 |
| Raymond James |
Locked
➜
Locked
|
Locked | Oct 13 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 08 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Oct 01 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Nov 13 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Oct 23 2025 |
|
Locked
Deutsche Bank:
Locked
➜
Locked
|
Oct 23 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Oct 23 2025 |
|
Locked
Raymond James:
Locked
➜
Locked
|
Oct 13 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 08 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Oct 01 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


